Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia

Paul SM, et al. Muscarine acetylcholine receptor agonists as novel treatments for schizophrenia. Am J Psychiatry. 2022;179(9):611-627.